A non-catalytic function of PI3Kγ drives smooth muscle cell proliferation after arterial damage
- 1 July 2020
- journal article
- research article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 133 (13)
Abstract
Arterial remodeling in hypertension and intimal hyperplasia involves inflammation and disrupted flow, both of which contribute to smooth muscle cell dedifferentiation and proliferation. In this context, our previous results identified phosphoinositide 3-kinase γ (PI3Kγ) as an essential factor in inflammatory processes of the arterial wall. Here, we identify for the first time a kinase-independent role of nonhematopoietic PI3Kγ in the vascular wall during intimal hyperplasia using PI3Kγ-deleted mice and mice expressing a kinase-dead version of the enzyme. Moreover, we found that the absence of PI3Kγ in vascular smooth muscle cells (VSMCs) leads to modulation of cell proliferation, associated with an increase in intracellular cAMP levels. Real-time analysis of cAMP dynamics revealed that PI3Kγ modulates the degradation of cAMP in primary VSMCs independently of its kinase activity through regulation of the enzyme phosphodiesterase 4. Importantly, the use of an N-terminal competing peptide of PI3Kγ blocked primary VSMC proliferation. These data provide evidence for a kinase-independent role of PI3Kγ in arterial remodeling and reveal novel strategies targeting the docking function of PI3Kγ for the treatment of cardiovascular diseases.Keywords
Funding Information
- Université de Toulouse
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale (FRM DPC20171138962)
- Fondation de France (201600066679)
- Agence Nationale de la Recherche (ANR-12-JSV1-0006-01)
This publication has 29 references indexed in Scilit:
- Phosphodiesterase 3A (PDE3A) Deletion Suppresses Proliferation of Cultured Murine Vascular Smooth Muscle Cells (VSMCs) via Inhibition of Mitogen-activated Protein Kinase (MAPK) Signaling and Alterations in Critical Cell Cycle Regulatory ProteinsJournal of Biological Chemistry, 2011
- A mTurquoise-Based cAMP Sensor for Both FLIM and Ratiometric Read-Out Has Improved Dynamic RangePLOS ONE, 2011
- Integrating Cardiac PIP3 and cAMP Signaling through a PKA Anchoring Function of p110γMolecular Cell, 2011
- PKA and Epac synergistically inhibit smooth muscle cell proliferationJournal of Molecular and Cellular Cardiology, 2011
- Genetic and Pharmacological Targeting of Phosphoinositide 3-Kinase-γ Reduces Atherosclerosis and Favors Plaque Stability by Modulating Inflammatory ProcessesCirculation, 2008
- Vascular Smooth Muscle Cell Phenotype-Dependent Phosphodiesterase 4D Short Form Expression: Role of Differential Histone Acetylation on cAMP-Regulated FunctionMolecular Pharmacology, 2005
- Assigning Functional Domains within the p101 Regulatory Subunit of Phosphoinositide 3-Kinase γJournal of Biological Chemistry, 2005
- Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and DiseasePhysiological Reviews, 2004
- Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double‐injury modelBritish Journal of Pharmacology, 2000
- Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in InflammationScience, 2000